The perinatal environment plays an important role in programming many aspects of physiology and behavior including metabolism, body weight set point, energy balance regulation and predisposition to mental health-related disorders such as anxiety, depression and attention deficit hyperactivity disorder. Maternal health and nutritional status heavily influence the early environment and have a long-term impact on critical central pathways, including the melanocortinergic, serotonergic system and dopaminergic systems. Evidence from a variety of animal models including rodents and nonhuman primates indicates that exposure to maternal high-fat diet (HFD) consumption programs offspring for increased risk of adult obesity. Hyperphagia and increased preference for fatty and sugary foods are implicated as mechanisms for the increased obesity risk. The effects of maternal HFD consumption on energy expenditure are unclear, and future studies need to address the impact of perinatal HFD exposure on this important component of energy balance regulation. Recent evidence from animal models also indicates that maternal HFD consumption increases the risk of offspring developing mental health-related disorders such as anxiety. Potential mechanisms for perinatal HFD programming of neural pathways include circulating factors, such as hormones (leptin, insulin), nutrients (fatty acids, triglycerides and glucose) and inflammatory cytokines. As maternal HFD consumption and obesity are common and rapidly increasing, we speculate that future generations will be at increased risk for both metabolic and mental health disorders. Thus, it is critical that future studies identify therapeutic strategies that are effective at preventing maternal HFD-induced malprogramming.

Keywords:
Energy balance, Energy expenditure, Obesity, Anxiety, Inflammation, Metabolic imprinting, Maternal high-fat diet
1.
Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010;303:235–241.
2.
Kopelman P: Health risks associated with overweight and obesity. Obes Rev 2007;8(suppl 1):13–17.
3.
Bachman KH: Obesity, weight management, and health care costs: a primer. Dis Manag 2007;10:129–137.
4.
Loos RJ: Recent progress in the genetics of common obesity. Br J Clin Pharmacol 2009;68:811–829.
5.
Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD: Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol E2000;279:E83–E87.
6.
Jones AP, Dayries M: Maternal hormone manipulations and the development of obesity in rats. Physiol Behav 1990;47:1107–1110.
7.
Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH, Harris M: Neonatal leptin treatment reverses developmental programming. Endocrinology 2005;146:4211–4216.
8.
Yura S, Itoh H, Sagawa N, Yamamoto H, Masuzaki H, Nakao K, Kawamura M, Takemura M, Kakui K, Ogawa Y, Fujii S: Role of premature leptin surge in obesity resulting from intrauterine undernutrition. Cell Metab 2005;1:371–378.
9.
D’Asti E, Long H, Tremblay-Mercier J, Grajzer M, Cunnane SC, Di Marzo V, Walker CD: Maternal dietary fat determines metabolic profile and the magnitude of endocannabinoid inhibition of the stress response in neonatal rat offspring. Endocrinology 2010;151:1685–1694.
10.
Augustyniak RA, Singh K, Zeldes D, Singh M, Rossi NF: Maternal protein restriction leads to hyper-responsiveness to stress and salt-sensitive hypertension in male offspring. Am J Physiol 2010;298:R1375–R1382.
11.
Sullivan EL, Grayson B, Takahashi D, Robertson N, Maier A, Bethea CL, Smith MS, Coleman K, Grove KL: Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring. J Neurosci 2010;30:3826–3830.
12.
Bilbo SD, Tsang V: Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB J 2010;24:2104–2115.
13.
King JC: Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr 2006;26:271–291.
14.
Alberti-Fidanza A, Parizkova J, Fruttini D: Relationship between mothers’ and newborns’ nutritional and blood lipid variables. Eur J Clin Nutr 1995;49:289–298.
15.
Oken E, Gillman MW: Fetal origins of obesity. Obes Res 2003;11:496–506.
16.
Levin BE: Synergy of nature and nurture in the development of childhood obesity. Int J Obes (Lond) 2009;33(suppl 1):S53–S56.
17.
Sullivan EL, Grove KL: Metabolic imprinting in obesity. Forum Nutr 2010;63:186–194.
18.
Sewell MF, Huston-Presley L, Super DM, Catalano P: Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol 2006.
19.
Abel EL, Reddy PP: Prenatal high saturated fat diet modifies behavioral effects of prenatal alcohol exposure in rats. Alcohol 1997;14:25–29.
20.
Brenneman DE, Rutledge CO: Effect of dietary lipid on locomotor activity and response to psychomotor stimulants. Psychopharmacology (Berl) 1982;76:260–264.
21.
Nakashima Y: Fish-oil high-fat diet intake of dams after day 5 of pregnancy and during lactation guards against excessive fat consumption of their weaning pups. J Nutr Sci Vitaminol (Tokyo) 2008;54:46–53.
22.
Wainwright PE, Huang YS, Bulman-Fleming B, Levesque S, McCutcheon D: The effects of dietary fatty acid composition combined with environmental enrichment on brain and behavior in mice. Behav Brain Res 1994;60:125–136.
23.
Raygada M, Cho E, Hilakivi-Clarke L: High maternal intake of polyunsaturated fatty acids during pregnancy in mice alters offsprings’ aggressive behavior, immobility in the swim test, locomotor activity and brain protein kinase C activity. J Nutr 1998;128:2505–2511.
24.
Guo F, Jen KL: High-fat feeding during pregnancy and lactation affects offspring metabolism in rats. Physiol Behav 1995;57:681–686.
25.
Levin BE, Govek E: Gestational obesity accentuates obesity in obesity-prone progeny. Am J Physiol 1998;275:R1374–R1379.
26.
Ferezou-Viala J, Roy AF, Serougne C, Gripois D, Parquet M, Bailleux V, Gertler A, Delplanque B, Djiane J, Riottot M, Taouis M: Long-term consequences of maternal high-fat feeding on hypothalamic leptin sensitivity and diet-induced obesity in the offspring. Am J Physiol 2007;293:R1056–R1062.
27.
Rolls BJ, Rowe EA: Pregnancy and lactation in the obese rat: effects on maternal and pup weights. Physiol Behav 1982;28:393–400.
28.
Rolls BJ, Rowe EA, Fahrbach SE, Agius L, Williamson DH: Obesity and high-energy diets reduce survival and growth rates of rat pups. Proc Nutr Soc 1980;39:51a.
29.
Rasmussen KM, Hilson JA, Kjolhede CL: Obesity may impair lactogenesis II. J Nutr 2001;131:3009s–3011s.
30.
McCurdy CE, Bishop JM, Williams SM, Grayson BE, Smith MS, Friedman JE, Grove KL: Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009;119:323–335.
31.
Samuelsson AM, Matthews PA, Argenton M, Christie MR, McConnell JM, Jansen EH, Piersma AH, Ozanne SE, Twinn DF, Remacle C, Rowlerson A, Poston L, Taylor PD: Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension 2008;51:383–392.
32.
Chang GQ, Gaysinskaya V, Karatayev O, Leibowitz SF: Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity. J Neurosci 2008;28:12107–12119.
33.
Walker CD, Naef L, D’Asti E, Long H, Xu Z, Moreau A, Azeddine B: Perinatal maternal fat intake affects metabolism and hippocampal function in the offspring: a potential role for leptin. Ann NY Acad Sci 2008;1144:189–202.
34.
Oscai LB, McGarr JA: Evidence that the amount of food consumed in early life fixes appetite in the rat. Am J Physiol 1978;235:R141–R144.
35.
Plagemann A, Heidrich I, Gotz F, Rohde W, Dorner G: Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding. Exp Clin Endocrinol 1992;99:154–158.
36.
Plagemann A, Harder T, Rake A, Waas T, Melchior K, Ziska T, Rohde W, Dorner G: Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats. J Neuroendocrinol 1999;11:541–546.
37.
Plagemann A, Harder T, Rake A, Voits M, Fink H, Rohde W, Dorner G: Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome X-like alterations in adulthood of neonatally overfed rats. Brain Res 1999;836:146–155.
38.
Grove KL, Grayson BE, Glavas MM, Xiao XQ, Smith MS: Development of metabolic systems. Physiol Behav 2005;86:646–660.
39.
Djiane J, Attig L: Role of Leptin during perinatal metabolic programming and obesity. J Physiol Pharmacol 2008;59(suppl 1):55–63.
40.
Grayson BE, Levasseur PR, Williams SM, Smith MS, Marks DL, Grove KL: Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet. Endocrinology 2010;151:1622–1632.
41.
Fisher JO, Birch LL: Fat preferences and fat consumption of 3- to 5-year-old children are related to parental adiposity. J Am Diet Assoc 1995;95:759–764.
42.
Eck LH, Klesges RC, Hanson CL, Slawson D: Children at familial risk for obesity: an examination of dietary intake, physical activity and weight status. Int J Obes Relat Metab Disord 1992;16:71–78.
43.
Bayol SA, Farrington SJ, Stickland NC: A maternal ‘junk food’ diet in pregnancy and lactation promotes an exacerbated taste for ‘junk food’ and a greater propensity for obesity in rat offspring. Br J Nutr 2007;98:843–851.
44.
Naef L, Srivastava L, Gratton A, Hendrickson H, Owens SM, Walker CD: Maternal high-fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl) 2008;197:83–94.
45.
Maniam J, Morris MJ: Palatable cafeteria diet ameliorates anxiety and depression-like symptoms following an adverse early environment. Psychoneuroendocrinology 2010;35:717–728.
46.
Vickers MH, Breier BH, McCarthy D, Gluckman PD: Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am J Physiol 2003;285:R271–R273.
47.
Rofey DL, Kolko RP, Iosif AM, Silk JS, Bost JE, Feng W, Szigethy EM, Noll RB, Ryan ND, Dahl RE: A longitudinal study of childhood depression and anxiety in relation to weight gain. Child Psychiatry Hum Dev 2009;40:517–526.
48.
Waring ME, Lapane KL: Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample. Pediatrics 2008;122:E1–E6.
49.
Kelley AE, Schiltz CA, Landry CF: Neural systems recruited by drug- and food-related cues: studies of gene activation in corticolimbic regions. Physiol Behav 2005;86:11–14.
50.
Teychenne M, Ball K, Salmon J: Physical activity, sedentary behavior and depression among disadvantaged women. Health Educ Res 2010;25:632–644.
51.
Macht M: How emotions affect eating: a five-way model. Appetite 2008;50:1–11.
52.
Kiyohara C, Yoshimasu K: Molecular epidemiology of major depressive disorder. Environ Health Prev Med 2009;14:71–87.
53.
Desai RA, Manley M, Desai MM, Potenza MN: Gender differences in the association between body mass index and psychopathology. CNS Spectr 2009;14:372–383.
54.
Leung TW, Lao TT: Placental size and large-for-gestational-age infants in women with abnormal glucose tolerance in pregnancy. Diabet Med 2000;17:48–52.
55.
Simerly RB: Hypothalamic substrates of metabolic imprinting. Physiol Behav 2008;94:79–89.
56.
Jones AP, Pothos EN, Rada P, Olster DH, Hoebel BG: Maternal hormonal manipulations in rats cause obesity and increase medial hypothalamic norepinephrine release in male offspring. Brain Res Dev Brain Res 1995;88:127–131.
57.
Plagemann A, Heidrich I, Gotz F, Rohde W, Dorner G: Lifelong enhanced diabetes susceptibility and obesity after temporary intrahypothalamic hyperinsulinism during brain organization. Exp Clin Endocrinol 1992;99:91–95.
58.
Bouret SG: Development of hypothalamic neural networks controlling appetite. Forum Nutr 2010;63:84–93.
59.
Lepercq J, Hauguel DE Mouzon S, Timsit J, Catalano PM: Fetal macrosomia and maternal weight gain during pregnancy. Diabetes Metab 2002;28:323–328.
60.
Hauguel DE Mouzon S, Shafrir E: Carbohydrate and fat metabolism and related hormonal regulation in normal and diabetic placenta. Placenta 2001;22:619–627.
61.
Davidowa H, Plagemann A: Decreased inhibition by leptin of hypothalamic arcuate neurons in neonatally overfed young rats. Neuroreport 2000;11:2795–2798.
62.
Grayson BE, Allen SE, Billes SK, Williams SM, Smith MS, Grove KL: Prenatal development of hypothalamic neuropeptide systems in the nonhuman primate. Neuroscience 2006;143:975–986.
63.
Grayson BE, Kievit P, Smith MS, Grove KL: Critical determinants of hypothalamic appetitive neuropeptide development and expression: species considerations. Front Neuroendocrinol 2010;31:16–31.
64.
Das UN: Is obesity an inflammatory condition? Nutrition 2001;17:953–966.
65.
Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR: Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007;92:969–975.
66.
Scarlett JM, Zhu X, Enriori PJ, Bowe DD, Batra AK, Levasseur PR, Grant WF, Meguid MM, Cowley MA, Marks DL: Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology 2008;149:4837–4845.
67.
Scarlett JM, Jobst EE, Enriori PJ, Bowe DD, Batra AK, Grant WF, Cowley MA, Marks DL: Regulation of central melanocortin signaling by interleukin-1β. Endocrinology 2007;148:4217–4225.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.